Precigen Inc $ 8.01 -0.6 (-6.97%)
Volume:
1,424,455
Avg Vol (1m):
1,476,840
Market Cap $:
1.49 Bil
Enterprise Value $:
1.59 Bil
P/E (TTM):
0.00
P/B:
22.63
Financial Strength | 2/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 0.52 | ||
Equity-to-Asset | 0.17 | ||
Debt-to-Equity | 3.74 | ||
Debt-to-EBITDA | -1.58 | ||
Piotroski F-Score | 4 | ||
Altman Z-Score | -5.04 | ||
Beneish M-Score | -5.05 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -114.02 | ||
Net Margin % | -295.57 | ||
ROE % | -300.81 | ||
ROA % | -68.9 | ||
ROC (Joel Greenblatt) % | -151.08 | ||
3-Year Revenue Growth Rate | -28.6 | ||
3-Year EBITDA Growth Rate | 9 | ||
3-Year EPS without NRI Growth Rate | 5.3 |
PGEN
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 22.63 | ||
PS Ratio | 12.86 | ||
EV-to-EBIT | -10.02 | ||
EV-to-EBITDA | -11.45 | ||
EV-to-Revenue | 15.79 | ||
Current Ratio | 4.93 | ||
Quick Ratio | 4.59 | ||
Days Inventory | 90.85 | ||
Days Sales Outstanding | 69 | ||
Days Payable | 27.04 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -11.2 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Earnings Yield (Greenblatt) % | -9.98 |